FUSIONTX Trademark

Trademark Overview


On Tuesday, March 15, 2022, a trademark application was filed for FUSIONTX with the United States Patent and Trademark Office. The USPTO has given the FUSIONTX trademark a serial number of 97313672. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, April 2, 2024. This trademark is owned by HighTide Therapeutics USA LLC. The FUSIONTX trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of chronic diseases of the digestive system; Pharmaceutical preparations for the treatment of chronic diseases of the digestive system; Therapeutic pharmaceutical for the treatment of diseases of the digestive system

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases of the digestive system
fusiontx

General Information


Serial Number97313672
Word MarkFUSIONTX
Filing DateTuesday, March 15, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, April 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements


Goods and ServicesPharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of chronic diseases of the digestive system; Pharmaceutical preparations for the treatment of chronic diseases of the digestive system; Therapeutic pharmaceutical for the treatment of diseases of the digestive system
Pseudo MarkFUSION TX
Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases of the digestive system

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, March 21, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHighTide Therapeutics USA LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRockville, MD 20852

Party NameHighTide Therapeutics USA LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRockville, MD 20852

Trademark Events


Event DateEvent Description
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024SOU EXTENSION 2 GRANTED
Tuesday, April 2, 2024SOU EXTENSION 2 FILED
Tuesday, April 2, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 3, 2023SOU EXTENSION 1 GRANTED
Tuesday, October 3, 2023SOU EXTENSION 1 FILED
Tuesday, October 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 26, 2022ASSIGNED TO EXAMINER
Wednesday, April 6, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 6, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 18, 2022NEW APPLICATION ENTERED